Qualification of Novel Immune Markers in Human Serum of Patients with MS
多发性硬化症患者人血清中新型免疫标志物的鉴定
基本信息
- 批准号:7932066
- 负责人:
- 金额:$ 5.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAutoimmune DiseasesCalculiCannabinoidsCentral Nervous System DiseasesClinical ResearchComplementary and alternative medicineDataDiseaseDoctor of PhilosophyEicosanoidsEndocannabinoidsEssential Fatty AcidsFellowshipFish OilsFundingGastrointestinal DiseasesGlaucomaGoalsHealedHealthHealth ProfessionalHumanImmuneImmunologic MarkersInflammatoryInterventionLeukocytesMeasuresMediatingMembraneMentorsMissionMolecular Mechanisms of ActionMultiple SclerosisNational Center for Complementary and Alternative MedicineNaturopathic DoctorNeurodegenerative DisordersOsteoporosisPatientsPeripheralPharmacologyPhospholipidsPlacebo ControlPlacebosProductionPublic HealthRandomizedRelapseResearchResearch PersonnelScienceSerumSignal TransductionSupplementationSystemTherapeuticTimeTrainingTraining SupportUniversitiesUnsaturated Fatty AcidsWashingtonbasecell motilitychronic paincosthealinghuman migrationimprovedinflammatory markerinterestlipid biosynthesisnervous system disordernoveloutcome forecastreceptorreceptor expression
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this fellowship proposal is to train Michelle Sexton, a Naturopathic Doctor (candidate June 2008), to become an independent researcher. In this mentored research plan, she will investigate the effects of fish oil supplementation, a common Complementary Alternative Medicine (CAM) therapy, on newly recognized markers of inflammation, namely the components forming the endocannabinoid (eCB) system. In order to achieve this goal, and as a stepping-stone into interdisciplinary mechanistic studies, the candidate will be sponsored by Nephi Stella PhD in the Pharmacology Department of the University of Washington.
The primary aims of this research are:
Aim 1: To measure endocannabinoids (eCBs) in human serum to determine if there is a difference between healthy subjects and patients with Multiple Sclerosis (MS). We will also evaluate whether supplementation with fish oil restores these levels.
Aim 2: To measure Cannabinoid 2 (CB2) receptor expression in human leukocytes.
Aim 3: To measure CB2 receptor-mediated migration by human leukocytes.
This study will also for the first time quantify eCBs in the periphery of patients with MS. This is significant for public health because the ability to modulate the functionality of the eCB signaling system by supplementing fish oil could provide low-cost, safe therapeutic benefit to patients with MS. This is relevant because there are approximately 300,000 patients in the US alone with MS. In addition, patients suffering from acute and chronic pain, autoimmune disease, gastrointestinal disorders, glaucoma, osteoporosis and a host of central nervous system disorders could also benefit from fish oil supplementation. All of these are conditions that have been shown to have an association with the eCB system. Funding of this proposal will be in accord with the missions of NCCAM which are:
* Explore complementary and alternative healing practices in the context of rigorous science.
* Train complementary and alternative medicine researchers.
* Disseminate authoritative information to the public and professionals.
This F32 will provide support for the training of a new investigator involved in research which will help the public and health professional understand more about mechanisms of action of a CAM therapy.
描述(由申请者提供):此奖学金提案的长期目标是培养自然疗法博士Michelle Sexton(2008年6月候选人)成为一名独立研究员。在这项有指导的研究计划中,她将调查补充鱼油--一种常见的补充替代医学(CAM)疗法--对新发现的炎症标志物,即构成内源性大麻素(ECB)系统的成分的影响。为了实现这一目标,并作为跨学科机械学研究的垫脚石,候选人将由华盛顿大学药理学系的Nephi Stella博士赞助。
这项研究的主要目的是:
目的1:检测多发性硬化(MS)患者和健康人血清中的内源性大麻素(ECB)水平,以确定两者之间是否存在差异。我们还将评估补充鱼油是否能恢复这些水平。
目的:检测人白细胞大麻素2(CB2)受体的表达。
目的3:检测CB2受体介导的人白细胞迁移。
这项研究还将首次量化MS患者周围的ECB这对公共健康具有重要意义,因为通过补充鱼油来调节欧洲央行信号系统功能的能力可以为MS患者提供低成本、安全的治疗益处。这一点是相关的,因为仅在美国就有大约30万MS患者。此外,患有急性和慢性疼痛、自身免疫性疾病、胃肠道疾病、青光眼、骨质疏松症和许多中枢神经系统疾病的患者也可以从补充鱼油中受益。所有这些情况都已被证明与欧洲央行体系有关。这项提议的资金将与NCCAM的任务相一致,这些任务是:
*在严谨的科学背景下探索互补和替代的治疗方法。
*培训补充和替代医学研究人员。
*向公众和专业人士传播权威信息。
F32将为培训一名新的研究人员提供支持,这将有助于公众和卫生专业人员更多地了解CAM疗法的作用机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle Sexton其他文献
Michelle Sexton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle Sexton', 18)}}的其他基金
Qualification of Novel Immune Markers in Human Serum of Patients with MS
多发性硬化症患者人血清中新型免疫标志物的鉴定
- 批准号:
7767684 - 财政年份:2008
- 资助金额:
$ 5.15万 - 项目类别:
Qualification of Novel Immune Markers in Human Serum of Patients with MS
多发性硬化症患者人血清中新型免疫标志物的鉴定
- 批准号:
7615219 - 财政年份:2008
- 资助金额:
$ 5.15万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别: